“
TL;DR
This is a protocol for a randomised controlled trial testing a 12-week integrated exercise and health education programme on 190 older adults at risk of cardiovascular disease, with physical activity at 24 weeks as the primary outcome.
PLOS ONE · 3 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a protocol for a randomised controlled trial testing a 12-week integrated exercise and health education programme on 190 older adults at risk of cardiovascular disease, with physical activity at 24 weeks as the primary outcome.
This paper describes the protocol for a randomised controlled trial. The study will randomise 190 community-dwelling Chinese adults aged 60 or above, who are at risk of ASCVD, to either a 12-week integrated exercise and cardiovascular health education programme or a placebo intervention. The primary outcome is physical activity level measured at Week 24. Secondary outcomes include exercise self-efficacy and various ASCVD-related physiological measures such as blood pressure, blood glucose, blood lipids, and cardiac endurance. The study will assess outcomes at baseline, Week 12, Week 24, and Week 36. Limitations include potential limited applicability to non-Chinese speakers, risk of absence in post-tests, and potential for contamination between groups.